Skip to main content
SpringerLink
Log in

Treatment of Dysmenorrhoea and Premenstrual Syndrome with Non-Steroidal Anti-Inflammatory Drugs

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

The menstrual cycle is associated with 2 potentially incapacitating events: dysmenorrhoea and premenstrual syndrome. Although substantial evidence has accumulated to indicate that excessive endometrial production of prostaglandin F2α is the major underlying cause of painful menstruation, correspondingly little is currently known about the basic aetiology of the premenstrual syndrome. Non-steroidal anti-inflammatory drugs have been used to alleviate the discomfort of both entities, and while these agents have come to assume a primary role in the treatment of dysmenorrhoea, a body of evidence substantiating their efficacy in premenstrual syndrome has yet to be developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abel MH, Baird DT. The effect of 17β estradiol and progesterone on prostaglandin production by human endometrium in organ culture. Endocrinology 106: 1599–1606, 1980

    PubMed  CAS  Google Scholar 

  • Akerlund M, Anderson KE, Ingemarsson I. Effects on terbulaline on myometrial activity, uterine blood flow, and lower abdominal pain in women with primary dysmenorrhoea. British Journal of Obstetrics and Gynaecology 83: 673–678, 1976

    PubMed  CAS  Google Scholar 

  • Anderson AB, Fraser IS, Haynes PJ, Turnbull AC. Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea. Lancet 1: 345–348, 1978

    PubMed  CAS  Google Scholar 

  • Anderson AB, Hayners PJ, Guilleband J, Turnbull AC. Reduction of menstrual blood loss by prostaglandin synthesis inhibitors. Lancet 1: 774–776, 1976

    PubMed  CAS  Google Scholar 

  • Anderscn B, Milsom I. An epidemiologic study of young women with dysmenorrhoea: American Journal of Obstetrics and Gynecology 144: 655–660, 1982

    Google Scholar 

  • Backstrom C, Boyl H, Baird D. Persistence of symptoms of premenstrual tension in hysterectomized women. British Journal of Obstetrics and Gynecology 88: 530–536, 1981

    CAS  Google Scholar 

  • Behrman HR. Prostaglandin in hypothalamopituitary and ovarian function. Annual Review of Physiology 41: 685–700, 1979

    PubMed  CAS  Google Scholar 

  • Black E. The treatment of dysmenorrhea with phenylbutazone. Canadian Medical Association Journal 79: 752–753, 1958

    PubMed  CAS  Google Scholar 

  • Bonney RC. Measurement of phospholipase A2activity in human endometrium during the menstrual cycle. Journal of Endocrinology 107: 183–189, 1985

    PubMed  CAS  Google Scholar 

  • Bricker W, Woods M. Premenstrual tension-rational treatment. Texas Reports on Biology and Medicine 9: 406–419, 1951

    Google Scholar 

  • Budoff PW. Use of prostaglandin inhibitors in the treatment of PMS. Clinical Obstetrics and Gynecology 30: 443–464, 1987

    Google Scholar 

  • Buttram V, Izu A, Henzl MR. Naproxen sodium in uterine pain following intrautenne contraceptive device insertion. American Journal of Obstetrics and Gynecology 134: 575–578, 1979

    PubMed  CAS  Google Scholar 

  • Carty TJ, Stevens JS, Lombardino JG, Parry MJ, Randall MJ. Piroxicam, a structurally novel anti-inflammatory compound mode of prostaglandin synthesis inhibition. Prostaglandins 19: 671–682, 1980

    PubMed  CAS  Google Scholar 

  • Champion GD, Graham GG. Pharmacokinetics of non-steroidal anti-inflammatory agents. Australian and New Zealand Journal of Medicine 8 (Suppl. 1): 94–100, 1978

    PubMed  Google Scholar 

  • Chan WY. Prostaglandin and non-steroidal anti-inflammatory drugs in dysmenorrhea. Annual Review of Pharmacology and Toxicology 23: 131–149, 1983

    PubMed  CAS  Google Scholar 

  • Chan WY, Dawood MY. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy. Advances in Prostaglandin and Thromboxane Research 8: 1443–1447, 1980

    PubMed  CAS  Google Scholar 

  • Chan WY, Dawood MY, Fuchs F. Relief of dysmenorrhea with prostaglandin synthesis inhibitor ibuprofen: effect on prostaglandin levels in menstrual fluid. American Journal of Obstetrics and Gynecology 135: 102–108, 1979

    PubMed  CAS  Google Scholar 

  • Chan WY, Dawood MY, Fuchs F. Prostaglandins in primary dysmenorrhea: comparison of prophylactic and nonprophylactic treatment with ibuprofen and use of oral contraceptives. American Journal of Medicine 70: 535–541, 1981

    PubMed  CAS  Google Scholar 

  • Chan WY, Hill JC. Determination of menstrual prostaglandin levels in nondysmenorrheic and dysmenorrheic subjects. Prostaglandins 15: 365–375, 1978

    PubMed  CAS  Google Scholar 

  • Cibils LA. Contractility of the nonpregnant human uterus. American Journal of Obstetrics and Gynecology 30: 441–459, 1967

    CAS  Google Scholar 

  • Coppen A, Kessel N. Menstruation and personality. British Journal of Psychiatry 109: 711–721, 1963

    PubMed  CAS  Google Scholar 

  • Csapo A, Pulkkinen MO, Henzl MR. The effect of naproxen sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients. Prostaglandins 13: 193–199, 1977

    PubMed  CAS  Google Scholar 

  • Dandenell LO, Lalos O, Lisciak J, Sandstrom B, Barany S, et al. Clinical experience of naproxen in the treatment of primary dysmenorrhea. Acta Obstetricia and Gynecologica Scandinavica 87: 95–100, 1979

    CAS  Google Scholar 

  • Dawood MY. Dysmenorrhea and prostaglandins: pharmacological and therapeutic considerations. Drugs 22: 42–56, 1981

    PubMed  CAS  Google Scholar 

  • Dick AC, Bellig HE, Macy HN. Menstrual exercises. Industrial Medicine and Surgery 12: 588–592, 1943

    Google Scholar 

  • Diem K, Shapiro S. The effect of ibuprofen in the treatment of dysmenorrhea. Current Therapeutic Research 30: 327–333, 1981

    Google Scholar 

  • Dingfelder JR. Primary dysmenorrhea treatment with prostaglandin inhibitors: a review. American Journal of Obstetrics and Gynecology 140: 874–877, 1981

    PubMed  CAS  Google Scholar 

  • Downie J, Poyser NL, Wunderlich M. Levels of prostaglandins in human endometrium during the normal menstrual cycle. Journal of Physiology 236: 465–472, 1974

    PubMed  CAS  Google Scholar 

  • DuRant RH, Jay S, Shoffett T, Lindner CW, Taylor W. Factors influencing adolescents’ responses to regimens of naproxen for dysmenorrhea. American Journal of Diseases of Children 139: 489–493, 1985

    PubMed  CAS  Google Scholar 

  • Eglinton G, Raphael RA, Smith GN, Gall WH, Pickles VR. Isolation and identification of two smooth muscle stimulants from menstrual fluid. Nature 200: 960–995, 1963

    PubMed  CAS  Google Scholar 

  • Ferreira SH, Vane JR. Prostaglandins: their disappearance from and release into the circulation. Nature 216: 868–873, 1967

    PubMed  CAS  Google Scholar 

  • Filler WW, Hall WC. Dysmenorrhea and its therapy: a uterine contractility study. American Journal of Obstetrics and Gynecology 106: 104–109, 1970

    PubMed  Google Scholar 

  • Flower R, Gryglewski R, Herbaczynska-Cedro K, Vane JR. Effect of anti-inflammatory drugs on prostaglandin biosynthesis. Nature: New Biology 238: 104–106, 1972

    CAS  Google Scholar 

  • Granstrom E. Prostaglandin biochemistry, pharmacy and physiological function. Acta Obstetricia et Gynecologica Scandinavica 113: 9–13, 1983

    CAS  Google Scholar 

  • Gullner HG. The interactions of prostaglandins with the sympathetic nervous system — a review. Journal of Autonomic Nervous System 8: 1–12, 1983

    CAS  Google Scholar 

  • Halbert DR, Demers LM, Fontant J, Jones DE. Prostaglandin levels in endometrial jet wash specimens in patients with dysmenorrhea before and after indomethacin therapy. Prostaglandins 10: 1047–1056, 1975

    PubMed  Google Scholar 

  • Hamber G, Samuelsson B. Detection and isolation of an endoperoxide intermediate in prostaglandin synthesis. Proceedings of the National Academy of Sciences 70: 899–908, 1973

    Google Scholar 

  • Hanson FW. Naproxen sodium, ibuprofen and a placebo in dysmenorrhea. Journal of Reproductive Medicine 27: 423–427, 1982

    PubMed  CAS  Google Scholar 

  • Harrison WM, Endicott J, Rabkin JG, Nee JC, Sandberg D. Treatment of premenstrual dysphoria with alprazolam and placebo. Psychopharmacology Bulletin 23: 150–153, 1987

    PubMed  CAS  Google Scholar 

  • Henzl MR, Ortega-Herrera E, Rodriguez C, Izu A. Anaprox in dysmenorrhea: reduction of pain and intrauterine pressure. American Journal of Obstetrics and Gynecology 135: 446–455, 1979

    Google Scholar 

  • Horrobin DF. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. Journal of Reproductive Medicine 28: 465–469, 1983

    PubMed  CAS  Google Scholar 

  • Jacobson J, Cavalli-Bjorkman K, Lundstrom V, Nilsson B, Norbeck M. Prostaglandin synthetase inhibitors and dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica 87 (Suppl.): 73–79, 1979

    CAS  Google Scholar 

  • Jacobson J, Lundsrom V, Nillson B. Naproxen in the treatment of OC-resistant primary dysmenorrhea. Acta Obstetricia Gynecologica Scandinavica 113 (Suppl.): 87–89, 1983

    CAS  Google Scholar 

  • Jakubowicz DL, Godard E, Dewhurst J. The treatment of premenstrual tension with mefenamic acid: analysis of prostaglandin concentrations. British Journal of Obstetrics and Gynaecology 91: 78–84, 1984

    PubMed  CAS  Google Scholar 

  • Johnson S. The epidemiology and social impact of premenstrual symptoms. Clinical Obstetrics and Gynecology 30: 367–376, 1987

    PubMed  CAS  Google Scholar 

  • Kajanoja P. Diflunisal compared with naproxen in the treatment of dysmenorrhea. Prostaglandins, Leukotrienes and Medicine 15: 153–158, 1984

    CAS  Google Scholar 

  • Kajanoja P, Vesanto T. Naproxen and indomethacin in the treatment of primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica 87 (Suppl.) 87: 87–89, 1979

    CAS  Google Scholar 

  • Kauppila A, Makila U-M, Makarainen J, Piolakka J, Seppala A. Tiaprofenic acid in the treatment of primary dysmenorrhea. European Journal of Obstetrics, Gynecology and Reproductive Biology 22: 359–363, 1986

    CAS  Google Scholar 

  • Kauppila A, Puolakka J, Ylikorkala O. The relief of primary dysmenorrhea by ketoprofen and indomethacin. Prostaglandins 18: 647–652, 1979

    PubMed  CAS  Google Scholar 

  • Kauppila A, Ylikorkala O. Indomethacin and tolfenamic acid in primary dysmenorrhea. European Journal of Obstetrics, Gynecology and Reproductive Biology 7: 59–64, 1977

    Google Scholar 

  • Lamb EJ, Palmisano G. Dysmenorrhea. In Peckham B & Shapiro S (Eds) Signs and symptoms in gynecology, JB Lippincott, Philadelphia, 1983

    Google Scholar 

  • Langrick AF. A study of naproxen sodium and mefenamic acid in primary dysmenorrhea. British Journal of Clinical Practice 37: 342–347, 1983

    PubMed  CAS  Google Scholar 

  • Levenson DJ, Summon CE, Brenner BM. Arachidonic acid metabolism, prostaglandins and the kidneys. American Journal of Medicine 72: 354–374, 1982

    PubMed  CAS  Google Scholar 

  • Levitt MJ, Tobin H, Josimovich JB. Prostaglandin content of human endometrium. Fertility and Sterility 26: 296–300, 1975

    PubMed  CAS  Google Scholar 

  • Lundstrom V. The myometrial response to intra-uterine administration of PGF2αand PGE2in dysmenorrheic women. Acta Obstetricia et Gynecologica Scandinavica 56: 167–172, 1977

    PubMed  CAS  Google Scholar 

  • Lundstrom V, Green K. Endogenous levels of prostaglandin F2ain plasma and endometrium of normal and dysmenorrheic women. American Journal of Obstetrics and Gynecology 130: 640–646, 1978

    PubMed  CAS  Google Scholar 

  • Lundstrom V, Green K, Kwanborg K. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility. Acta Obstetricia et Gynecologica Scandinavica 87 (Suppl.): 51–56, 1979

    CAS  Google Scholar 

  • Lundstrom V, Green K, Wigurst N. Prostaglandins, indomethacin and dysmenorrhea. Prostaglandins 11: 893–903, 1976

    PubMed  CAS  Google Scholar 

  • Markiewicz L, Schatz F, Barg F, Gurpide E. Prostaglandin F2αoutput by human endometrium under superfusion and organ culture conditions. Journal of Steroid Biochemistry 22: 231–235, 1985

    PubMed  CAS  Google Scholar 

  • Marsh CC, Schuma AA, Sundstrom N. A review of selected investigational non-steroidal anti-inflammatory drugs of the 1980s. Pharmacotherapy 6: 10–25, 1986

    PubMed  CAS  Google Scholar 

  • Martin JN, Bygdeman M. The effect of locally administered PGF2αon the contractility of the non-pregnant uterine in vivo. Prostaglandins 10: 253–265, 1975

    PubMed  CAS  Google Scholar 

  • Martin JN, Bygdeman M, Eneroth P. The influence of locally administered prostaglandin E2and F2αon uterine motility in the intact non-pregnant human uterus. Acta Obstetricia et Gynecologica Scandinavica 57: 141–147, 1978

    PubMed  CAS  Google Scholar 

  • Mathe AA, Hedqvist P, Strandberg K, Leslie CA. Aspects of prostaglandin function in the lung. New England Journal of Medicine 296: 910–914, 1977

    PubMed  CAS  Google Scholar 

  • Milson I, Andersch B. Effect of ibuprofen, naproxen sodium and paracetamol on intrauterine pressure and menstrual pain in dysmenorrhea. British Journal of Obstetrics and Gynaecology 91: 1129–1135, 1984

    Google Scholar 

  • Milson I, Andersch B. Ibuprofen and naproxen sodium in the treatment of primary dysmenorrhea. International Journal of Gynaecology and Obstetrics 23: 305–310, 1985

    Google Scholar 

  • Mira M, McNeil D, Fraser IS, Vizzard J, Abraham S. Mefenamic acid in the treatment of premenstrual syndrome. Obstetrics and Gynecology 68: 395–398, 1986

    PubMed  CAS  Google Scholar 

  • Moiir CH. Recording of the contractions of the human pregnant and non-pregnant uterus. Edinburgh Medical Journal 41: 93–120, 1934

    Google Scholar 

  • Muse KN, Cetel NS, Futterman LA, Yen SC. The premenstrual syndrome: effects of ‘medical ovariectomy’. New England Journal of Medicine 311: 1345–1349, 1984

    PubMed  CAS  Google Scholar 

  • Owen PR. Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. American Journal of Obstetrics and Gynecology 148: 96–103, 1984

    PubMed  CAS  Google Scholar 

  • Parker AS. The premenstrual tension syndrome. Medical Clinics of North America 44: 339–348, 1960

    PubMed  Google Scholar 

  • Pendergast BD. Primary dysmenorrhea. US Pharmacist 1: 41–54, 1984

    Google Scholar 

  • Pickles VR. A plain muscle stimulant in the menstrum. Nature 180: 1198–1199, 1957

    PubMed  CAS  Google Scholar 

  • Pickles VR, Hall W, Best FA, Smith GN. Prostaglandins in endometrium and menstrual fluid from normal and dysmenorrheic subjects. British Journal of Obstetrics and Gynaecology 72: 185–192, 1965

    CAS  Google Scholar 

  • Piper PJ, Vane J. The release of prostaglandins from lung and other tissues. Annals of the New York Academy of Sciences 180: 363–383, 1971

    PubMed  CAS  Google Scholar 

  • Pulkkinen MO. Prostaglandin and the non-pregnant uterus. Acta Obstetricia et Gynecologica Scandinavica 113 (Suppl.): 63–67, 1983

    CAS  Google Scholar 

  • Pulkkinen MO, Csapo AI. The effects of ibuprofen on the intrauterine pressure and menstrual pain of dysmenorrheic patients. Prostaglandins 15: 1055–1062, 1978

    PubMed  CAS  Google Scholar 

  • Pulkkinen MO, Csapo AI. Effect of ibuprofen on menstrual blood prostaglandin levels in dysmenorrheic women. Prostaglandins 18: 137–142, 1979

    PubMed  CAS  Google Scholar 

  • Puolakka J, Makarainen L, Viinikka L, Ylikorkala O. Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors. Journal of Reproductive Medicine 30: 149–153, 1985

    PubMed  CAS  Google Scholar 

  • Rees MC, DiMarjo V, Tippins JR, Morris HR, Turnbull AC. Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhea and menorrhagia. Journal of Endocrinology 113: 291–295, 1987

    PubMed  CAS  Google Scholar 

  • Rees MC, Parry DM, Anderson AB, Turnbull AC. Immunohistochemical localization of cyclooxygenase in the human uterus. Prostaglandins 23: 207–214, 1982

    PubMed  CAS  Google Scholar 

  • Reid RL, Yen SS. Premenstrual syndrome. American Journal of Obstetrics and Gynecology 139: 85–104, 1981

    PubMed  CAS  Google Scholar 

  • Rosenwaks Z, Jones GS, Henzl MR, Dubin OH, Ghodgaonkar RB, et al. Naproxen sodium, aspirin and placebo in primary dysmenorrhea: reduction of pain and blood levels of prostaglandin F2αmetabolite. American Journal of Obstetrics and Gynecology 140: 592–598, 1981

    PubMed  CAS  Google Scholar 

  • Roy S. A double-blind comparison of propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea. Obstetrics and Gynecology 61: 628–632, 1983

    PubMed  CAS  Google Scholar 

  • Rubinow DR, Roy-Byrne P. Premenstrual syndromes: overview from a methodologie perspective. American Journal of Psychiatry 141: 163–172, 1984

    PubMed  CAS  Google Scholar 

  • Ruble DN. Menstrual symptoms: a reinterpretation. Science 197: 291–292, 1977

    PubMed  CAS  Google Scholar 

  • Sampson JA. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. British Journal of Psychiatry 185: 209–215, 1979

    Google Scholar 

  • Sampson JA, Prescott P. The assessment of the symptoms of premenstrual syndrome and their response to therapy. British Journal of Psychiatry 138: 399–405, 1981

    PubMed  CAS  Google Scholar 

  • Samuelsson B. Biosynthesis of prostaglandins. Federation Proceedings 31: 1442–1450, 1972

    PubMed  CAS  Google Scholar 

  • Schatz F, Markiewicz L, Barg P, Gurpide E. In vitro effects of ovarian steroids on prostaglandin F2αoutput by human endometrium and endometrial epithelial cells. Journal of Clinical Endocrinology 61: 361–367, 1985

    CAS  Google Scholar 

  • Segre EJ. Naproxen sodium: pharmacology, pharmacokinetics and drug interactions. Journal of Reproductive Medicine 25 (Suppl. 4): 222–225, 1980

    PubMed  CAS  Google Scholar 

  • Sekhar NC. Effects of 8 prostaglandins on platelet aggregation. Journal of Medical Chemistry 13: 39–44, 1970

    CAS  Google Scholar 

  • Serfaty D. A comparative crossover study of piroxicam vs mefenamic acid and dyclofenac in France. Acta Obstetricia et Gynecologica Scandinavica 138 (Suppl.): 19–20, 1986

    CAS  Google Scholar 

  • Shapiro S. Flurbiprofen for the treatment of primary dysmenorrhea. American Journal of Medicine 80: 71–75, 1986

    PubMed  CAS  Google Scholar 

  • Shapiro S, Diem K. The effect of ibuprofen in the treatment of dysmenorrhea. Current Therapeutic Research 30: 327–333, 1981

    Google Scholar 

  • Shapiro S, Haning RV. Ibuprofen inhibits endometrial prostaglandin F2αduring menstruation. Current Therapeutic Research 33: 380–384, 1983

    Google Scholar 

  • Singh EJ, Baccarini IM, Zuspan FP. Levels of prostaglandins F2αand E2in human endometrium during the menstrual cycle. American Journal of Obstetrics and Gynecology 121: 1003–1006, 1975

    PubMed  CAS  Google Scholar 

  • Smith OW. Menstruation. American Journal of Obstetrics and Gynecology 54: 201–211, 1947

    PubMed  CAS  Google Scholar 

  • Smith RJ, Sabin C, Gilchrest H, Williams S. Effect of anti-inflammatory drugs on lysosomes and lysosomal enzymes from rat liver. Biochemical Pharmacology 25: 2171–2177, 1976

    PubMed  CAS  Google Scholar 

  • Smith RP. Distribution analysis of intrauterine pressure in nonpregnant dysmenorrheic women. American Journal of Obstetrics and Gynecology 149: 271–273, 1984

    PubMed  CAS  Google Scholar 

  • Smith S, Rinehart JS, Ruddock VE, Schiff I. Treatment of premenstrual syndrome with alprazolam: results of a double-blind, placebo-controlled, randomized crossover clinical trial. Obstetrics and Gynecology 70: 37–43, 1987

    PubMed  CAS  Google Scholar 

  • Speroff L, Glass RH, Kase NG. Clinical gynecologic endocrinology and infertility, 3rd ed., Williams and Wilkins, Baltimore, 1983

    Google Scholar 

  • Stenson WF, Parker CW. Prostaglandins and the human immune response. In Lee JB (Ed.) Prostaglandins, pp. 39–90, Elseview North Holland, New York, 1982

    Google Scholar 

  • Stromberg P, Akerlund M, Forsling E, Granstrom E, Kindahl H. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Acta Obstetricia et Gynecologica Scandinavica 63: 533–538, 1984

    PubMed  CAS  Google Scholar 

  • Sturgis SH, Albright F. The mechanism of estrin therapy in the relief of dysmenorrhea. Endocrinology 26: 68–72, 1940

    CAS  Google Scholar 

  • Tolman EL, Partridge R. Multiple sites of interaction between prostaglandins and non-steroidal anti-inflammatory agents. Prostaglandins 9: 349–359, 1975

    PubMed  CAS  Google Scholar 

  • Ulmsten U, Andersson K-E, Forman MB. Relaxing effects of mefedipine on the non-pregnant human uterus in vitro and in vivo. Obstetrics and Gynecology 52: 436–441, 1978

    PubMed  CAS  Google Scholar 

  • Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature: New Biology 321: 232–235, 1971

    Google Scholar 

  • Van Order DE, Swanson JA, Clancey CJ, Farley DB. Plasma prostaglandins in the normal menstrual cycle. Obstetrics and Gynecology 50: 639–643, 1977

    Google Scholar 

  • Virutomosen P, Wright KH, Wallach EE. Effects of prostaglandin E2and F2on ovarian contractility in the rabbit. Fertility and Sterility 26: 678, 1972

    Google Scholar 

  • Wilson L, Kurzrok R. Studies on the motility of the human uterus in vivo. Endocrinology 23: 79–86, 1938

    CAS  Google Scholar 

  • Wittkower E, Wilson AT. Dysmenorrhea and sterility, personality studies. British Medical Journal 2: 586–590, 1940

    PubMed  CAS  Google Scholar 

  • Wood C, Jakubowicz. The treatment of premenstrual symptoms with mefenamic acid. British Journal of Obstetrics and Gynecology 87: 627–630, 1980

    CAS  Google Scholar 

  • Woodbury PA, Torpen R, Child GP, Watson H, Jarboe M. Myometrial physiology and its relations to pelvic pain. Journal of the American Medical Association 134: 1081–1085, 1947

    PubMed  CAS  Google Scholar 

  • Ylikorkala O, Dawood M. New concepts in dysmenorrhea. American Journal of Obstetrics and Gynecology 130: 833–847, 1978

    PubMed  CAS  Google Scholar 

  • Zurier RB. Prostaglandins and inflammation. In Lee JB (Ed.) Prostaglandins, pp. 91–112, Elsevier North Holland, New York, 1982

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Wisconsin, 600 Highland Avenue, H4/630 CSC, Madison, WI, 53792, USA

    Sander S. Shapiro

Authors
  1. Sander S. Shapiro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shapiro, S.S. Treatment of Dysmenorrhoea and Premenstrual Syndrome with Non-Steroidal Anti-Inflammatory Drugs. Drugs 36, 475–490 (1988). https://doi.org/10.2165/00003495-198836040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198836040-00005

Keywords

Search

Navigation